Registration form
Remind me later

Pediatric hematopoietic stem cell transplantation in Lithuania – 20 years of progress through collaboration

Date, time
Thu, May 26 2022, 9:00 - Fri, May 27 2022, 17:00
Location
Vilnius university
P
Pediatric hematopoietic stem cell transplantation in Lithuania – 20 years of progress through collaboration
CREATIVA
Tickets no available yet? Remind me later
Price
Vardas ir pavardė sertifikate bus įrašyti taip, kaip nurodysite formoje
Print information HERE
Conference secretariat | CREATIVA +370 60378930 violeta@creativa.lt
Lector list:
  • Lector name
    Town, Country
Price
Conference program
September 22, 2022 Thursday 10:00 – 18:30
10:00 – 12:00
Session I: Pediatric HSCT in Baltic countries
10:00 - 10:15
Welcome prof. Feliksas Jankevičius, VUHSK General Director prof. Algirdas Utkus, The Dean of the Medical Faculty, Vilnius University Speaker TBD. Lithuanian Ministry of Health.
10:15 – 10:35
Pediatric hematopoietic stem cell transplantation in Lithuania – 20 years of progress through collaboration Assoc. Prof. Jelena Rascon, Vilnius University Hospital Santaros Klinikos, Lithuania
10:35 – 10:40
Q&A
10:40 – 11:05
Lithuanian Bone Marrow Donor Registry Rita Čekauskienė, MD, Vilnius University Hospital Santaros Klinikos, Lithuania
11:05 – 11:20
Pre- and post-transplant care of Latvian children: achievements and challenges Speaker TBD
11:20 – 11:25
Q&A
11:25 – 11:40
Pediatric hematopoietic stem cell transplantation in Estonia Speaker TBD
11:40 – 11:45
Q&A
11:45 – 12:00
Break
12:00 – 13:30
Session II: HSCT in non-malignant disorders Moderators: TBD
12:00 – 12:40
Advances in HSCT for congenital bone marrow failure syndromes Assoc. Prof. Kasiani C. Myers, MD, PhD, Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
12:40 – 12:45
Q&A
12:45 – 13:25
Haploidentical HSCT for patients with non-malignant disorders Prof. Franco Locatelli, MD, PhD, IRCCS Ospedale Pediatrico Bambino Gesu, Rome, Italy (TBC)
13:25 – 13:30
Q&A
13:30 – 14:30
Lunch
14:30 – 16:30
Session III: Management of leukemia relapse Moderators: TBD
14:30 – 14:50
Outcomes of relapsed/refractory ALL – Lithuanian experience Assoc. prof. Goda Elizabeta Vaitkeivičienė, Vilnius University Hospital Santaros Klinikos, Lithuania
14:50 – 14:55
Q&A
14:55 – 15:25
Blinatumomab – current state-of-part Prof. Franco Locatelli, MD, PhD, IRCCS Ospedale Pediatrico Bambino Gesu, Rome, Italy (TBC)
15:25 – 15:30
Q&A
15:30 – 16:00
CAR-T cell therapy Jochen Buchner, MD, Oslo University Hospital (TBC)
16:00 – 16:05
Q&A
16:05 – 16:35
Baltic experience with Blinatumomab/CAR-T cells Lithuania, Speaker TBD Latvia, Speaker TBD Estonia, Speaker TBD
16:35 – 16:45
Q&A
16:45 – 17:00
Break
17:00 – 18:30
Session IV: Early post-transplant toxicities Moderators: TBD
17:00 – 17:40
The Challenges of TMA: potransplant TTP/a HUS Sonata Jodele, MD, PhD, Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
17:40 – 17:45
Q&A
17:45 – 18:00
Acute Kidney Injury in Children After Allogeneic HSCT Karolis Ažukaitis, MD, PhD Vilnius University Hospital Santaros Klinikos, Lithuania
18:00 – 18:05
Q&A
17:45 – 18:25
Prognostic biomarkers in liver sinusoid obstructive syndrome Klaus Muller, MD, Rigshospitalet, Copenhagen, Denmark (TBC)
18:25 – 18:30
Q&A
September 23, 2022 Friday 10:00 – 18:30
08:00 – 11:00
Session V: Educational session
Moderators: TBD
08:00 - 08:40
Multifactorial pathway of transplant toxicities Sonata Jodele, MD, PhD, Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
08:40 - 08:45
Q&A
08:45 – 09:15
Selected rapid-fire presentations by trainees and fellows (TBD) Q&A
09:15 – 09:30
Break
09:30 – 13:30
Session VI: Cellular therapies

Moderators: TBD
09:30 – 10:00
Mesenchymal and NK Cell Therapy Prof. Peter Bader, Wolfgang Goethe University, Frankfurt, Germany
10:00 – 10:05
Q&A
10:05 – 10:20
Covid-19- and other virus-specific T-cell Therapy Adomas Bukauskas, MD, Vilnius University Hospital Santaros Klinikos, Lithuania
10:20 – 10:25
Q&A
10:25 – 10:40
Role of Biobanking in Rare and Newly Emerging Disease Daniel Naumovas, Vilnius University Hospital Santaros Klinikos, Lithuania
10:40 – 10:45
Q&A
10:45 – 11:00
Biobanking in Estonia Daniel Naumovas, Vilnius University Hospital Santaros Klinikos, Lithuania
11:00 – 11:05
Q&A
11:05 – 11:15
Free paper
11:15 – 11:20
Q&A
11:20 – 11:40
Break
11:40 – 13:30
Session VII: Late toxicities Moderators: TBD
11:40 – 12:10
Bronchiolitis obliterans Assoc. Prof. Kasiani C. Myers, MD, PhD, Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
12:10 – 12:15
Q&A
12:15 – 12:27
Nitrogen multiple breath washout for lung injury assessment in HSCT recipients Paulius Kalbatas, MD, Vilnius University Hospital Santaros Klinikos, Lithuania
12:27 – 12:30
Q&A
12:30 – 12:45
Fertility Preservation facilities at VUHSK Raminta Baušyte, MD, Vilnius University Hospital Santaros Klinikos, Lithuania
12:45 – 12:50
Q&A
12:50 – 13:05
Assessment of fertility counseling in pediatric cancer patients Eglė Stukaitė-Ruibienė on behalf of the TREL project, Vilnius University, Lithuania
13:05 – 13:10
Q&A
13:10 – 13:25
Free-paper presentation
13:25 – 13:30
Q&A
13:30 – 14:30
Lunch
14:30 – 16:30
Session VIII: Quality management and strategy for the future Moderators: TBD
14:30 – 15:00
JACIE accreditation Eoin MacGrath, EBMT (TBC)
15:00 – 15:05
Q&A
15:05 – 15:25
Management of SARS-CoV-2 infection in oncohematological patients – what have we learned? Eoin MacGrath, EBMT (TBC)
15:25 – 15:30
Q&A
15:05 – 15:25
Management of SARS-CoV-2 infection in oncohematological patients – what have we learned? Kazimieras Maneikis, MD, Vilnius University Hospital Santaros Klinikos, Lithuania
15:25 – 15:30
Q&A
15:30 – 16:00
Free-paper presentations
16:00 – 16:30
Round-table discussion – roadmap of pediatric HSCT in the Baltic countries Representatives of Lithuania, Latvia and Estonia (TBD)